86 related articles for article (PubMed ID: 7475644)
1. Nef vaccination against HIV disease.
Montagnier L
Lancet; 1995 Oct; 346(8983):1170. PubMed ID: 7475644
[No Abstract] [Full Text] [Related]
2. Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides.
Bourgault I; Chirat F; Tartar A; Lévy JP; Guillet JG; Venet A
J Immunol; 1994 Mar; 152(5):2530-7. PubMed ID: 8133061
[TBL] [Abstract][Full Text] [Related]
3. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
[TBL] [Abstract][Full Text] [Related]
4. Simian retrovirus vaccines: simian retrovirus and simian immunodeficiency lentivirus.
Gardner MB; Luciw PA; Sawai ET; Marthas ML; Miller CJ; McChesney MB; Lerche NW; Pedersen NC
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):399-401. PubMed ID: 8882318
[No Abstract] [Full Text] [Related]
5. Current approaches to vaccination against human immunodeficiency viruses.
Gluckman JC; Yagello M; Bahraoui E; Girard M
Allergol Immunopathol (Madr); 1991; 19(1):11-3. PubMed ID: 1719790
[No Abstract] [Full Text] [Related]
6. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
7. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
[TBL] [Abstract][Full Text] [Related]
8. Vaccines based on Nef and on Nef/DeltaV2 Env.
Erfle V; Goebel FD; Guzman CA; Le Grand R
Microbes Infect; 2005 Nov; 7(14):1400-4. PubMed ID: 16243564
[TBL] [Abstract][Full Text] [Related]
9. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs.
Ui M; Kuwata T; Igarashi T; Ibuki K; Miyazaki Y; Kozyrev IL; Enose Y; Shimada T; Uesaka H; Yamamoto H; Miura T; Hayami M
Virology; 1999 Dec; 265(2):252-63. PubMed ID: 10600597
[TBL] [Abstract][Full Text] [Related]
10. HIV pathogenesis: Nef loses control.
Foster JL; Garcia JV
Cell; 2006 Jun; 125(6):1034-5. PubMed ID: 16777594
[TBL] [Abstract][Full Text] [Related]
11. Specific proliferative T cell responses and antibodies elicited by vaccination with simian immunodeficiency virus Nef do not confer protection against virus challenge.
Wade-Evans AM; Stott J; Hanke T; Stebbings R; Berry N; Lines J; Sangster R; Silvera P; Walker B; MacManus S; Davis G; Cowie J; Arnold C; Hull R; Almond N
AIDS Res Hum Retroviruses; 2001 Nov; 17(16):1517-26. PubMed ID: 11709096
[TBL] [Abstract][Full Text] [Related]
12. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
Calarota SA; Kjerrström A; Islam KB; Wahren B
Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
[TBL] [Abstract][Full Text] [Related]
13. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
[TBL] [Abstract][Full Text] [Related]
15. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
[TBL] [Abstract][Full Text] [Related]
16. Functional evaluation of HIV/SIV Nef as superantigen.
Lapatschek MS; Dürr S; Sutter G; Wagner H; Miethke T
Virology; 2001 Apr; 282(2):329-37. PubMed ID: 11289815
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.
Couillin I; Letourneur F; Lefèbvre P; Guillet JG; Martinon F
Virology; 2001 Jan; 279(1):136-45. PubMed ID: 11145897
[TBL] [Abstract][Full Text] [Related]
18. Criteria for selection of HIV vaccine candidates--general principles.
Ensoli B
Microbes Infect; 2005 Nov; 7(14):1433-5. PubMed ID: 16213181
[TBL] [Abstract][Full Text] [Related]
19. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
[TBL] [Abstract][Full Text] [Related]
20. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.
Ferko B; Stasakova J; Sereinig S; Romanova J; Katinger D; Niebler B; Katinger H; Egorov A
J Virol; 2001 Oct; 75(19):8899-908. PubMed ID: 11533153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
